Pharma-Bio Serv (PBSV) Total Liabilities (2010 - 2026)

Pharma-Bio Serv's Total Liabilities history runs 16 years deep, the most recent figure standing at $1.0 million for Q2 2026.

• Quarterly Total Liabilities fell 41.29% year-over-year to $1.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.0 million (down 41.29% YoY) and the FY2025 annual result came in at $1.7 million, down 32.52% from the prior year.
• Total Liabilities was $1.0 million for Q2 2026 at Pharma-Bio Serv, down from $3.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $5.1 million in Q1 2024 and bottomed at $1.0 million in Q2 2026.
• A 5-year average of $3.3 million and a median of $3.8 million in 2023 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities sank 47.86% — and 2024, when it climbed 29.79%.
• Pharma-Bio Serv's Total Liabilities stood at $4.1 million in 2022, then declined by 7.77% to $3.8 million in 2023, then plunged by 31.74% to $2.6 million in 2024, then sank by 32.52% to $1.7 million in 2025, then plunged by 39.89% to $1.0 million in 2026.
• Business Quant data shows PBSV's Total Liabilities at $1.0 million in Q2 2026, $3.3 million in Q1 2026, and $1.7 million in Q4 2025.